Vincristine Sulfate is Used for treating Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in adults who have relapsed multiple times or progressed after multiple therapies. It was first introduced by Eli Lilly And Co in its drug Oncovin on Approved Prior to Jan 1, 1982. Another drug containing Vincristine Sulfate is Marqibo Kit. 9 different companies have introduced drugs containing Vincristine Sulfate.

Vincristine Sulfate Patents

Given below is the list of patents protecting Vincristine Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Marqibo Kit	US7247316	Compositions and methods for treating lymphoma	Sep 25, 2020 (Expired)	Acrotech
Marqibo Kit	US6723338	Compositions and methods for treating lymphoma	Mar 31, 2020 (Expired)	Acrotech
Marqibo Kit	US7887836	Compositions and methods for treating lymphoma	Mar 31, 2020 (Expired)	Acrotech
Marqibo Kit	US5543152	Sphingosomes for enhanced drug delivery	Jun 20, 2014 (Expired)	Acrotech
Marqibo Kit	US5741516	Sphingosomes for enhanced drug delivery	Jun 20, 2014 (Expired)	Acrotech
Marqibo Kit	US5814335	Sphingosomes for enhanced drug delivery	Jun 20, 2014 (Expired)	Acrotech

Add above patents to watchlist

Vincristine Sulfate's Family Patents

Full family tree

Vincristine Sulfate Generic API Manufacturers

Several generic applications have been filed for Vincristine Sulfate. The first generic version for Vincristine Sulfate was by Abraxis Pharmaceutical Products and was approved on Sep 10, 1986. And the latest generic version is by Fresenius Kabi Usa Llc and was approved on Oct 28, 2003.

Given below is the list of companies who have filed for Vincristine Sulfate generic, along with the locations of their manufacturing plants worldwide.